The Effects of DHA- and EPA-enriched Oils on Cognitive Function and Mood

Launched by NORTHUMBRIA UNIVERSITY · May 4, 2016

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged 25 to 49 years inclusive
• • Males and females
• • Self-report of good health
• Exclusion Criteria:
• • English is not first language (some of the cognitive tasks have only been validated in native English speakers)
• • Habitual consumption of oily fish exceeds one fish meal per week
• • Habitual consumption of omega-3 dietary supplements in the previous 6 months
• • Habitual use of dietary supplements within the last month (defined as more than 3 consecutive days or 4 days in total; some supplements that do not impact upon cognitive function e.g. garlic, protein, calcium are allowed. Please check with the research team if you are unsure)
• • Are a smoker or consume any nicotine replacement products (e.g. chewing gum, e-cigarettes)
• • Food allergies or sensitivities to any of the ingredients contained in the investigational product or any other foodstuff
• • Pregnant, trying to get pregnant or breast feeding
• • Body Mass Index outside of the range 18-35 kg/m2
• • High blood pressure (systolic over 159 mm Hg or diastolic over 99 mm Hg)
• • Currently taking blood pressure medication
• • Currently taking blood thinning medication (e.g. aspirin, warfarin, heparin)
• • Have a respiratory disorder that requires regular medication (Note: participants with asthma who only take their medication occasionally/as required are eligible for this study)
• • Have frequent migraines that require medication (more than or equal to 1 per month)
• • History or current diagnosis of drug/alcohol abuse
• • History of kidney or liver disease, or other severe diseases of the gastrointestinal tract (e.g. iron accumulation, iron utilization disorders, hypercalcaemia, hypercalcaemia), that are likely to interfere with metabolism/absorption/secretion of the product under investigation
• • History of neurological or psychiatric illness (excluding depressive illness and anxiety)
• • History of head trauma
• • Sleep disturbances and/or are taking sleep aid medication
• • Blood disorders (e.g. anaemia, haemophilia, thrombocytosis)
• • Diagnosis of type I or type II diabetes
• • Heart disorder, or vascular illness
• • Current diagnosis of depression and/or anxiety
• • Over- or under-active thyroid
• • Chronic gastrointestinal problems (e.g. Inflammatory Bowel Disease, Irritable Bowel Syndrome, celiac disease)
• • Any known active infections
• • Diagnosed with or may be at risk of having syphilis, hepatitis, the Human T - lymphotropic virus or the Human Immunodeficiency Virus
• • Current or past breast cancer diagnosis and/or a mastectomy
• • Health condition that would prevent fulfilment of the study requirements
• • Currently participating in or in the past 4 weeks participated in other clinical or nutrition intervention studies